Pancreatic kininogenase enteric-coated tablets are mostly taken on an empty stomach before meals. When patients take pancreatic kininogenase enteric-coated tablets, the drug acts in the gastrointestinal tract, after being absorbed by the blood, it continues to act on the pancreatic islet cells, regulates the secretion of insulin α and insulin β, and regulates the level of insulin, which is usually taken on an empty stomach, if patients take it after meals, it will be due to the impact of food on the level of insulin secretion and the time of secretion, which will lead to abnormalities of blood glucose in the patients, and the concentration of the drug should not be achieved. In addition pancreatic kininogenase enteric coated tablets, there will be nausea, vomiting, skin rash and other adverse reactions, when the patient’s adverse reactions are too serious, it is recommended to stop using the drug. Patients should consult a physician before using the drug, under the guidance of the physician to use the drug, not blindly choose the drug.